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ABSTRACT 
Background/Aim: Reduced-exertion high-intensity interval training (REHIT) is a genuinely 
time-efficient intervention that can improve aerobic capacity (V̇O2max) and insulin sensitivity 
in sedentary individuals. The present study compared the effects of REHIT and moderate-
intensity walking on health markers in patients with type 2 diabetes (T2D) in a counter-
balanced crossover study.  
Methods: Sixteen men with T2D (mean±SD age: 55±5 y, BMI: 30.6±2.8 kg·m-2, V̇O2max: 
27±4 mL·kg-1·min-1) completed 8 weeks of REHIT (three 10-min low-intensity cycling 
sessions/week with two 'all-out' 10-20-s sprints) and 8 weeks of moderate-intensity walking 
(five 30-min sessions/week at an intensity corresponding to 40-55% of heart-rate reserve), with 
a 2-month wash-out period between interventions. Before and after each intervention, 
participants underwent an incremental fitness test, an oral glucose tolerance test (OGTT), a 
whole body dual-energy X-ray absorptiometry (DXA) scan, and continuous glucose 
monitoring.  
Results: REHIT was associated with a significantly larger increase in V̇O2max compared to 
walking (7% vs. 1%; time x intervention interaction effect: p<0.05). Both REHIT and walking 
decreased resting mean arterial pressure (MAP, -4%; main effect of time: p<0.05) and plasma 
fructosamine (-5%; main effect of time: p<0.05). Neither intervention significantly improved 
OGTT-derived measures of insulin sensitivity, glycaemic control measured using continuous 
glucose monitors, blood lipid profile or body composition. 
Conclusions: We conclude that REHIT is superior to a five-fold larger volume of moderate-
intensity walking in improving aerobic fitness, but similar to walking REHIT is not an effective 
intervention for improving insulin sensitivity or glycaemic control in T2D patients in the short 
term.  
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INTRODUCTION 
With an estimated 422 million people worldwide suffering from type 2 diabetes (T2D) in 2014 
(NCD Risk Factor Collaboration, 2016), and a predicted increase to 592 million by 2035 
(Guariguata et al., 2014), T2D represents an increasingly serious burden on global health. A 
clear link between a sedentary lifestyle and the development of T2D has been demonstrated in 
prospective studies (Albright et al., 2000), and exercise can be used as an effective treatment 
modality (Colberg et al., 2010). The primary objectives of exercise interventions in T2D are to 
improve insulin sensitivity and glycaemic control, but considering the substantial burden of 
comorbidities in T2D patients, improving aerobic fitness, blood pressure, blood lipid profile, 
and body composition are important secondary objectives. For example, low V̇O2max is a 
strong predictor of mortality in T2D (Wei et al., 2000), and it has been suggested that besides 
encouraging reductions in sedentary time and increases in overall physical activity levels, 
improving V̇O2max should also be a key objective (Bouchard et al., 2015; Lee et al., 2011). 
Similarly, although T2D patients are at increased risk of cardiovascular disease (Colberg et al., 
2010), even small decreases in blood pressure (2.1/0.9 mm Hg systolic/diastolic) can reduce 
major cardiovascular events by 10% (Turnbull et al., 2005).  
Although the physical activity recommendations for patients with T2D (Colberg et al., 2010) 
and the general population (Garber et al., 2011) are essentially the same, adherence to these 
recommendations by T2D patients is even lower than in the general population (Morrato et al., 
2007). As lack of time has been identified as one of the key barriers to performing sufficient 
physical activity in T2D patients (Korkiakangas et al., 2009), there is a need for effective 
interventions that are more time-efficient. High-intensity interval training (HIT) has been 
proposed to represent a promising, time-efficient alternative/adjunct to aerobic exercise 
(Earnest, 2008). Meta-analyses have demonstrated that, compared to aerobic exercise, HIT is 
more effective at improving insulin resistance (Jelleyman et al., 2015) and V̇O2max (Milanovic 
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et al., 2015) in healthy sedentary individuals. In T2D patients, HIT has been shown to be 
associated with improvements in insulin sensitivity (Karstoft et al., 2014), glycaemic control 
(Little et al., 2011), and endothelial function (Madsen et al., 2015). However, due to the 
required recovery periods in between high-intensity bouts, most available HIT protocols are 
not as time-efficient as often claimed (Gillen & Gibala, 2014), and even in submaximal HIT 
protocols the high number of high-intensity bouts per training session results in high perceived 
exertion (Little et al., 2011). Moreover, repeating sprints more than ~4 times has a negative 
impact on the affective response to HIT (Frazão et al., 2016).  
Based on the hypothesis that the mechanisms for the beneficial effects of HIT may be linked 
to the rapid glycogen depletion associated with supramaximal exercise (Metcalfe et al., 2012; 
Metcalfe et al., 2015; Metcalfe et al., 2016), and the observation that glycogen depletion during 
supramaximal exercise is limited to the first ~15 seconds of the first bouts of repeated ‘all-out’ 
sprints (Parolin et al., 1999), we have developed a shorter and more manageable version of 
HIT, termed reduced-exertion HIT (REHIT) (Metcalfe et al., 2012; Metcalfe et al., 2016). The 
REHIT protocol, which involves two brief ‘all-out’ cycle sprints within a 10-min exercise 
session, is associated with improved insulin sensitivity and V̇O2max in sedentary individuals 
(Metcalfe et al., 2012; Metcalfe et al., 2016). Similar results have been obtained with a REHIT 
protocol modified by Martin Gibala’s group to include three sprints instead of two (Gillen et 
al., 2016; Gillen et al., 2014). Recently, Revdal et al. (2016) studied the effects of a treadmill-
based version of REHIT on cardiometabolic risk factors in T2D patients, and observed 
improved V̇O2max and diastolic blood pressure following 12 weeks of training, but no changes 
in glycaemic control or body composition. However, peak power output data were not reported, 
and it is unclear whether this treadmill-based protocol is comparable to our cycling-based 
(Wingate) protocol in the exercise intensities achieved, or the associated adaptations. 
Furthermore, there are conflicting data on whether patients with T2D will have enhanced 
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(Jenkins & Hagberg, 2011), or impaired (Layne et al., 2011; Sriwijitkamol et al., 2007) 
responses to exercise training in general, and therefore it remains unknown whether cycling-
based REHIT can be used to improve insulin sensitivity and V̇O2max in T2D patients, and 
whether it may be effective at improving other important health markers such as blood pressure, 
blood lipid profile, and body composition. Moreover, in order for any intervention to be 
recommended to patients with T2D, the effects of the intervention should be at least as good 
as those associated with current physical activity recommendations. Considering the high 
interindividual variability in response to standardised supervised training interventions for 
important cardiometabolic risk factors such as V̇O2max, insulin sensitivity, blood lipid profile, 
blood pressure and body composition (Bouchard & Rankinen, 2001; Metcalfe et al., 2016; 
Vollaard et al., 2009), it is clear that randomised controlled trials that compare HIT vs. aerobic 
exercise require large sample sizes in order to avoid being affected by random inclusion of 
more low or high responders in one of the groups. An alternative approach is to perform studies 
with a cross-over design, allowing comparison of differences in the efficacy between 
interventions within individuals. Thus, the aim of the present study was to compare the effects 
of an 8-week REHIT intervention vs. 8 weeks of moderate-intensity aerobic exercise on 
V̇O2max, OGTT-derived insulin sensitivity, glycaemic control measured using continuous 
glucose monitoring, blood lipid profile, blood pressure and body composition in patients with 
T2D using a cross-over design. Based on our previous findings in sedentary but healthy 
individuals (Metcalfe et al., 2012; Metcalfe et al., 2016) we hypothesised that REHIT would 
be associated with improvements in these cardiometabolic risk factors, and that the 
improvements would be comparable to those with moderate-intensity aerobic exercise.   
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MATERIALS AND METHODS 
Participants 
Twenty-one men with T2D were recruited through the local UK South West Primary Care 
Research Network and local advertisement. Volunteers were eligible for participation if they 
were diagnosed with T2D by a clinician at least 6 months prior to the start of the study 
according to standard criteria (fasting blood glucose ≥7.0 mmol·l-1 and/or 2-h oral glucose 
tolerance test blood glucose ≥11.1 mmol·l-1), were not on exogenous insulin therapy or more 
than two anti-diabetic drugs, and had no contraindications to exercise, including cardiac 
disease, impaired liver or renal function, or uncontrolled hypertension. Further exclusion 
criteria were BMI>35 kg·m-2, age <40 y or >60 y, any abnormalities on a resting ECG, and 
classification as highly physically active on the International Physical Activity Questionnaire 
(IPAQ). Participants were informed of the experimental protocol both verbally and in writing 
before providing informed consent. Ethical approval was obtained from the NHS National 
Research Ethics Service (South West England REC; 13/SW/0298). Five participants dropped 
out during the study (Figure 1); participant characteristics for the remaining sixteen 
participants are shown in Table 1. No participants reported changes in their medication during 
the study. 
Pre-experimental procedures  
An overview of the experimental procedures is shown in Figure 2. Seven days prior to the first 
testing day, participants performed a familiarisation session for the maximal incremental 
cycling test to volitional exhaustion. Intensity was increased by 1 W every 4 s following a 5-
min warm-up at 50 W (Excalibur, Lode, Groningen, the Netherlands). V̇O2max was determined 
as the highest 15-breath rolling average for V̇O2 measured using an online gas analysis system 
(TrueOne 2400, Parvo Medics, Sandy, UT, US). Values for V̇O2max were accepted if two or 
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more of the following criteria were met: 1) volitional exhaustion, 2) RER>1.10, and 3) maximal 
heart rate within 10 beats of the age-predicted maximum (i.e. 220-age). This was the case for 
all tests performed. 
Testing procedures 
Testing days were scheduled before each intervention, and 3 days after the last training session 
of each intervention. Seven days prior to each of the testing days, participants were fitted with 
a combined heart-rate monitor / accelerometer (Actiheart, CamNtech, Oxford, UK), which was 
worn up to and including the testing day, and used to calculate the participants’ mean physical 
activity level (PAL) (Loney et al., 2011). A diet record was completed for the 3 days prior to 
the pre-training testing day and analysed using dietary analysis software (Nutritics v3.74, 
Dublin, Ireland). Participants abstained from their anti-diabetic medication the day before and 
the day of testing. For each participant, a meal was provided by the research team for the 
evening before testing (chosen by the participant from a number of options; total energy: 
3321±660 kJ; 16±4% protein, 46±9% carbohydrate, 38±10% fat). Participants received the 
same evening meal before each of the four testing days in order to control for variation in 
results associated with diet. On the testing day, participants reported to the lab in the morning 
after an overnight fast for measurement of body composition using a whole body dual-energy 
X-ray absorptiometry (DXA) scan (Hologic Discovery W, Waltham, MA, USA). Following 
the scan a continuous subcutaneous glucose monitor (CGM; iPro, Medtronic, Northridge, 
California, USA) was fitted to the abdomen for measurement of glucose levels over the 
subsequent ~20 hrs. The CGM device was calibrated through capillary blood sampling at 
regular intervals during the day when blood glucose levels were expected to be stable 
(FreeStyle Freedom Lite, Abbott Diagnostics, Maidenhead, UK). A cannula was then inserted 
into a superficial forearm vein for use during an oral glucose tolerance test (OGTT). 
Participants then sat at rest for 30 minutes before three consecutive measurements of systolic 
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(SBP) and diastolic (DBP) blood pressure (Alvita MC101). Mean arterial pressure (MAP) was 
calculated as 2/3 DBP + 1/3 SBP. The OGTT started 30 min later with the collection of a 
baseline blood sample in a 4-ml EDTA-tube before drinking 113 mL of Polycal (Nutricia 
Clinical Care, UK) dissolved in 87 mL of water (equivalent to a 75 g glucose load). Further 
blood samples were taken 30, 60, 90 and 120 min later. Samples were kept on ice before 
centrifugation to obtain plasma for storage at -80°C, and subsequent analysis for glucose 
(Randox RX Daytona, Co. Antrim, UK) and insulin (ELISA, Dako, Ely, UK). Area under the 
curve (AUC) for the glucose and insulin responses was calculated using the trapezoid model, 
and peripheral insulin sensitivity was determined using the Cederholm Index (Cederholm & 
Wibell, 1990). Baseline (t=0) plasma samples were also analysed for triglycerides, LDL, HDL, 
fructosamine, and alanine transaminase (Randox RX Daytona, Co. Antrim, UK). For the 
remainder of the day, diet was standardised by providing the participants with set meals and 
snacks at set times (total energy: 8797±1327 kJ; 14±2% protein, 53±5% carbohydrate, 34±5% 
fat). As with the evening meal prior to the testing day, the same food items were provided for 
each of the four testing days. Participants returned to the lab the following day for removal of 
the glucose monitor. A maximal incremental cycling test to volitional exhaustion was repeated 
as described above.  
Exercise interventions  
Participants completed two 8-week supervised exercise interventions (REHIT and walking), 
spaced 2 months apart (range: 7-10 weeks) in a randomised counter-balanced crossover design 
(Figure 2). Eight participants performed the REHIT intervention first, which involved three 
10-min sessions per week consisting of cycling at 25 W (Corival, Lode, Groningen, the 
Netherlands) interspersed with one (first session) or two (all remaining sessions) Wingate-type 
cycle-sprints against a constant torque of 0.65 Nm·kg lean mass-1. Sprints lasted 10 s in sessions 
1-4, 15 s in sessions 5-12, and 20 s in the remaining 12 sessions. The peak power output (PPO), 
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mean power output (MPO), and the power output at the end of the sprint (EPO), as well as 
heart rate (Polar RS400, Polar, Kempele, Finland) were recorded for all sessions. The walking 
intervention was based on guidelines provided by the American College of Sports Medicine 
and the American Diabetes Association (Colberg et al., 2010), and involved five 30-min 
walking sessions per week at an intensity corresponding to 40%, 50% and 55% of heart-rate 
reserve (HRR) in weeks 1 and 2, weeks 3 and 4, and weeks 5-8 respectively. In order to keep 
the number of visits to the lab the same between the two interventions, three of the five weekly 
walking sessions were performed in the lab, and the remaining two sessions were performed at 
a place of the participant’s choice, with a heart rate monitor (Polar RS400) to monitor the 
exercise intensity. Rating of perceived exertion (RPE) was recorded using a standard 6-20 scale 
during the final session of each training week. Training characteristics for both interventions 
are summarised in Table 2. In order to be included in the main data analysis, participants were 
not allowed to miss more than 20% of the training sessions in total, 3 consecutive sessions, or 
the final session before post-intervention testing sessions for either intervention. None of the 
participants failed to meet these requirements. The importance of returning to their usual 
lifestyle during the break in between the first and second exercise intervention was explained 
to the participants. After completing the study, but prior to receiving their individual results, 
participants were asked which of the two interventions would have their preference if they were 
asked to continue one of them. 
Statistical Analysis 
Data are presented as mean±SD. A power analysis (β=0.80, α=0.05) based on the primary 
outcome measure (change in OGTT-derived insulin sensitivity (Cederholm Index)) indicated 
that ≥16 participants were required to be able to detect significant differences between the two 
interventions with an effect size (Cohen’s d) of 0.75. The effects of the interventions on the 
measured variables were analysed using two-way repeated-measures ANOVA (intervention 
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[REHIT / WALK] x time [pre-training / post-training]), with the intervention x time interaction 
effect as the main statistic of interest. Potential temporal effects were also analysed using two-
way repeated-measures ANOVA (intervention [first / second] x time [pre-training / post-
training]). Alpha was set at 0.05.  
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RESULTS 
Training characteristics 
On average the participants completed 99% of the REHIT sessions and 97% of the walking 
sessions. The training sessions were well-tolerated and no adverse events were observed, or 
reported by the participants. Mean RPE scores for the REHIT intervention (13.6±1.1; 
‘somewhat hard’) were significantly higher than for the walking intervention (11.7±1.2; ‘light’; 
p<0.001; Table 2). Peak power output (PPO), mean power output (MPO) and end power output 
(EPO) were all significantly lower in the second sprint compared to the first sprint (p<0.001), 
and MPO and EPO decreased during the intervention as sprint duration increased (p<0.001; 
Table 2). Mean total energy intake, and energy contribution from carbohydrates, fats and 
protein for the 3 days prior to the testing days were not significantly different between the 4 
trials (data not shown). There was a significant time x intervention interaction effect for 
ActiHeart-derived mean physical activity level (PAL) for the 7 days prior to the testing days 
(p<0.05), reflecting a slight increase in physical activity energy expenditure during the final 
week of the walking intervention compared to pre-training (mean±SD 24-h activity level: 
1.44±0.12 vs. 1.45±0.13 METs), and a slight decrease during the final week of the REHIT 
intervention (1.45±0.09 vs 1.38±0.10 METs). Twelve out of sixteen participants indicated a 
preference for REHIT as their intervention of choice. 
Training effects on cardiometabolic health markers 
Mean pre- and post-intervention values for the measured parameters are shown in Table 3. 
There was a significant time x intervention interaction effect for V̇O2max (p<0.05) with a 7% 
increase following REHIT and a 1% increase following the walking intervention. MAP, SBP 
and DBP improved following exercise (main effect of time: p<0.05), but there were no 
significant time x intervention interaction effects for these parameters. There was a significant 
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positive correlation between the percentage change scores for MAP following the REHIT and 
walking interventions (R2=0.32, p<0.05), but no such correlation was observed for V̇O2max 
(R2=0.06, NS). OGTT-derived measures of insulin sensitivity, glycaemic control as measured 
by CGM, blood measures, and body composition were not significantly affected by either 
REHIT or walking, except for a small training-induced decrease in plasma fructosamine levels 
(main effect of time: p<0.05). 
Effectiveness of the wash-out period and order effects 
The 2-month wash-out period between the two interventions was effective, as demonstrated by 
the lack of any significant differences between the first and second intervention for the baseline 
(pre-intervention) mean values for any of the measured parameters. Furthermore, the 
significant interaction effect for V̇O2max could not be explained by potential superior effects 
during the first or second intervention as there were no intervention x time interaction effects 
for V̇O2max for the first and second intervention (data not shown).  
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DISCUSSION 
Using a cross-over design, the present study compared the effects of the genuinely time-
efficient REHIT intervention and moderate-intensity aerobic exercise on health markers in 
patients with T2D. Although following 8 weeks of training neither intervention significantly 
improved glycaemic control as determined using CGM or OGTT-derived insulin sensitivity, 
both interventions reduced blood pressure to a similar extent, and REHIT was superior to 
moderate-intensity walking in improving V̇O2max. This was despite the fact that the total 
training time-commitment for the REHIT intervention was 80% lower than for the walking 
intervention (30 min per week vs. 150 min per week). This is the first study to compare the 
health benefits of two exercise interventions in a sample of T2D patients using a cross-over 
design. This provides a more powerful approach than the more commonly used randomised 
controlled trial approach, which to achieve the same power to detect a difference between two 
interventions would have required 56 participants compared to the sample of n=16 used in the 
present study. 
In previous studies we (Metcalfe et al., 2012) and others (Gillen et al., 2016; Gillen et al., 2014) 
have demonstrated that very low volumes of sprint exercise are sufficient to significantly 
improve measures of insulin sensitivity in sedentary people on average, but with large 
interindividual variability in response (Metcalfe et al., 2016). Conversely, with a similar 
protocol and a longer intervention duration (8 weeks vs. 6 weeks), in the present study we did 
not observe improvements in glycaemic control as measured using a continuous glucose 
monitor, or OGTT-derived measures of insulin sensitivity in T2D patients. This is in line with 
the recent findings by Revdal et al. (2016) who observed improvements in V̇O2max but not 
glycaemic control following 12 weeks of a running-based REHIT intervention. Interestingly, 
in contrast to data presented by Little et al. (2011), a HIT protocol consisting of 10 x 1 min at 
90% of maximal heart rate was also found to be ineffective at improving glycaemic control in 
15 
 
the study by Revdal et al. (2016). This highlights the fact that the results of studies investigating 
the effects of exercise interventions on insulin sensitivity have been conflicting. Whereas some 
studies have reported greater benefits of exercise in people with poorer baseline insulin 
sensitivity (Jenkins & Hagberg, 2011), others have reported impaired responses to exercise in 
patients with T2D or metabolic syndrome (Layne et al., 2011; Sriwijitkamol et al., 2007), and 
longer T2D disease duration is associated with poorer improvements in insulin sensitivity and 
glycaemic control following aerobic exercise training (Solomon et al., 2013). In addition, it has 
been suggested that low response to exercise for important risk factors such as V̇O2max or 
insulin sensitivity may result in increased risk of developing cardiometabolic disease (Lessard 
et al., 2013). If this is indeed the case, then it could be expected that low response to exercise 
is more prevalent in patient populations compared to healthy individuals. Thus, patients with 
T2D may require a larger dose and/or intensity of exercise training in order to improve insulin 
sensitivity. The present study suggests that neither 150 min of moderate-intensity walking nor 
30 min of REHIT per week provide a sufficient training stimulus to improve OGTT-derived 
insulin sensitivity and glycaemic control in this patient group within an 8-week intervention 
duration. 
An alternative explanation for the lack of effect for insulin sensitivity in patients with T2D is 
the potential interfering effect of medication. It has been demonstrated that metformin may 
attenuate the beneficial effects of exercise on glucose regulation, blood pressure, and blood 
lipid profile (Malin & Braun, 2016). Similarly, studies suggest that statins may attenuate 
exercise-induced adaptations as well (Mikus et al., 2013; Murlasits & Radak, 2014), although 
the opposite effect has also been observed (Meex et al., 2010). As our study was not sufficiently 
powered for a between-participant statistical comparison of the training adaptations in 
participants who were taking statins and/or metformin (n=12) vs. the participants who were not 
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(n=4), we cannot determine whether the use of medication may have affected the response to 
training in the present study. 
In contrast to the lack of effect for OGTT-derived insulin sensitivity, REHIT significantly 
improved V̇O2max and MAP. Considering the strong association between an increase in 
V̇O2max and reduced all-cause and cardiovascular disease mortality (Barlow et al., 2012; Lee 
et al., 2011), this is an important finding. Similarly, the 5, 2 and 4 mm Hg reductions in systolic, 
diastolic and mean arterial pressure, respectively, following 8 weeks of REHIT favourably 
compare to the effects of blood pressure-lowering medication in T2D patients and can be 
expected to lead to a reduction in cardiovascular morbidity and mortality in the longer term 
(Turnbull et al., 2005). Thus we demonstrate that cardiovascular risk in a patient population at 
increased risk can be reduced with an exercise intervention which only requires 30 min of total 
training time per week. Although based on these findings alone it is too early to advise patients 
to perform REHIT rather than moderate-intensity aerobic exercise, they provide initial support 
for the use of REHIT in patients who feel they do not have sufficient time to follow current 
exercise recommendations. As the majority of participants in our study preferred the REHIT 
intervention over the walking intervention, and no adverse events occurred, further research 
into the effects of very low volumes of HIT in patient populations is warranted. 
Neither of the interventions resulted in changes in body composition. This is not entirely 
surprising because the participants were informed that the objective of the study was not weight 
loss and they were encouraged to keep their diet and lifestyle habits stable for the duration of 
the study. Furthermore, previous larger studies have also demonstrated that 150 min per week 
of moderate intensity exercise is insufficient for weight loss (Church et al., 2007). Considering 
previous findings of superior weight loss with HIT vs. moderate intensity aerobic exercise 
(Trapp et al., 2008), and indications that an acute REHIT session affects appetite-regulating 
hormones (Metcalfe et al., 2015), it will be worthwhile to investigate in future studies whether 
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a combination of REHIT with a calorie-restricted diet may provide an effective means of 
adiposity management. 
The safety of HIT interventions in patients remains a contentious issue. Despite the fact that 
there are no data to suggest that HIT is inherently less safe to perform by patients than aerobic 
or resistance exercise, opponents of the use of HIT in patients maintain the argument that the 
high exercise intensities must make HIT less safe (Biddle & Batterham, 2015; Holloway & 
Spriet, 2015). It remains unknown whether the short-term increase in heart rate associated with 
high-intensity exercise (reaching ~90% of maximal heart rate in our study) is more or less of a 
risk compared to the more sustained longer-term increase in heart rate during aerobic exercise. 
However, in our opinion the expected increase in blood flow and blood pressure during sprints 
presents the main potential risk of HIT. Only limited data is currently available on the acute 
responses for these parameters during and directly after HIT (Hussain et al., 1996), and this 
should be the focus of more detailed future studies. Nonetheless, in the present study we 
observed no adverse events associated with performing ‘all-out’ cycle sprints (mean±SD peak 
power output: ~350±50% of V̇O2max) in sixteen overweight/obese, middle-aged (43-60 y) 
patients with T2D. Although this does not ‘prove’ that REHIT is safe for T2D patients (‘safety’ 
is a difficult concept to demonstrate experimentally), our study at a minimum provides 
additional support for the safety of REHIT as an intervention for sedentary individuals in the 
general population.  
It has been proposed that caution is needed before advocating HIT interventions to the general 
population because the high exercise intensities will decrease motivation and may evoke a high 
degree of negative affect (Hardcastle et al., 2014). This may (Frazão et al., 2016; Saanijoki et 
al., 2015), or may not (Freese et al., 2014; Jung et al., 2014) be the case for HIT protocols that 
rely on many (4-10) longer (30-60 s) sprints, but the ratings of perceived exertion in response 
to two 20-s sprints as used in the REHIT protocol in the present study appear to be manageable, 
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and the majority of participants (12 out of 16) stated a preference for performing REHIT rather 
than the walking intervention based on current physical activity recommendations. There is 
therefore an urgent need to perform further studies examining the efficacy, acceptability, and 
longer-term adherence to REHIT as a practical ‘real-life’ intervention.  
In conclusion, we demonstrate that brief bouts of REHIT are well-tolerated by middle-aged 
men with T2D, and that this type of training is superior to a five-times larger total volume of 
moderate-intensity walking in improving V̇O2max. Furthermore, 8 weeks of both REHIT and 
walking are associated with a significant decrease in blood pressure in T2D patients, but the 
reasons why these patients do not respond to either intervention, on average, for glycaemic 
control and OGTT-derived insulin sensitivity needs to be investigated further.   
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Table 1 Participant characteristics (n=16) 
Age (y) 55±5 (43-60) 
Duration of T2D (y since diagnosis) 4±4 (1-11) 
Body mass (kg) 96.7±11.1 (72.4-113.6) 
Height (m) 1.78±0.06 (1.68-1.87) 
BMI (kg·m-2) 30.6±2.8 (25.1-34.5) 
V̇O2max (mL·kg-1·min-1) 27.5±4.3 (21.3-34.1) 
Systolic blood pressure (mm Hg) 132±12 (118-157) 
Diastolic blood pressure (mm Hg) 82±7 (67-95) 
Mean arterial pressure 99±8 (86-116) 
Medication:  
 None (n) 3 
 Metformin (n) 9 
 Sulfonylurea (n) 3 
 Blood pressure lowering (n) 4 
 Statins (n) 10 
 Anti-depressant (n) 1 
Values shown are mean±SD (range) 
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Table 2 Training characteristics 
 REHIT Walking 
 Sessions 1-4 Sessions 5-12 Sessions 13-24 Sessions 1-10 Sessions 11-20 Sessions 21-40 
RPE 13±1 14±1 14±2 11±1 12±2 12±1 
HRpeak (% of HRmax) 86±6 87±6 88±6 - - - 
Target vs. achieved HR (bpm) - - - 
110±10 / 111±10 120±10 / 121±10 126±11 / 125±12 
PPO (sprint 1/sprint 2; W) 784±129 / 759±115 778±149 / 769±127 765±137 / 757±151 - - - 
MPO (sprint 1/sprint 2; W) 626±105 / 618±105 602±105 / 589±103 564±96 / 532±89 - - - 
EPO (sprint 1/sprint 2; W) 505±100 / 500±99 451±73 / 421±90 393±92 / 342±78 - - - 
RPE: rating of perceived exertion; HR: heart rate; HRR: heart rate reserve; PPO: peak power output; MPO: mean power output; EPO: end power output 
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Table 3 Effects of the two training interventions (n=16) 
 Pre-REHIT Post-REHIT Pre-Walking Post-Walking 
Body mass (kg) 96.8±11.7 97.1±12.0 97.0±11.6 97.2±11.9 
Total body fat (%) 31.0±4.3 30.7±4.3 30.9±4.4 30.9±4.5 
Android fat (%) 37.9±5.3 37.5±5.3 37.8±5.1 37.6±5.8 
Gynoid fat (%) 28.0±5.1 27.3±5.1 * 28.1±5.4 27.7±5.4 * 
V̇O2max (L·min-1) 2.60±0.44 2.79±0.47 † 2.64±0.45 2.66±0.49 † 
Systolic blood pressure (mm Hg) 132±13 127±10 * 132±11 130±17 * 
Diastolic blood pressure (mm Hg) 81±8 78±6 * 82±8 78±6 * 
Mean arterial pressure (mm Hg) 98±9 94±7 * 99±8 95±9 * 
CGM average glucose (mM) 9.5±2.9 9.5±3.2 9.7±3.4 9.7±2.8 
Fasted plasma glucose (mmol·L-1) 9.9±3.0 9.2±2.2 9.9±2.8 9.7±2.3 
Fasted plasma insulin (mU·L-1) 16.0±11.6 16.1±13.6 13.7±10.1 17.7±13.9 
HOMA-IR 7.1±5.2 6.6±5.4 6.2±4.8 7.5±5.3 
OGTT plasma glucose AUC (mmol·min·L-1) 1848±543 1758±396 1893±483 1848±435 
OGTT plasma insulin AUC (mU·min·L-1) 3395±679 3579±987 3563±612 3584±947 
Cederholm index (mg·L2·mmol-1·mU-1·min-1) 23.3±12.1 24.7±14.0 21.6±11.0 22.5±10.3 
Triglycerides (mM) 1.5±0.8 1.4±0.7 1.5±0.9 1.4±0.7 
Plasma LDL (mM) 2.9±1.7 3.2±1.8 2.8±1.4 2.6±1.5 
Plasma HDL (mM) 1.0±0.2 1.1±0.2 1.1±0.2 1.1±0.2 
Plasma fructosamine (μM) 387±65 376±56 * 396±54 366±69 * 
Plasma ALT (U/L) 36±8 36±9 37±12 38±13 
Values shown are mean±SD. V̇O2max: maximal aerobic capacity, CGM: continuous glucose monitor 
HOMA-IR: homeostatic model assessment - insulin resistance, OGTT: oral glucose tolerance test, 
AUC: area-under-the-curve, NEFA: non-esterified fatty acids, LDL: low-density lipoprotein, HDL: 
high-density lipoprotein, ALT: alanine aminotransferase. Main effect of time: * p<0.05; trial x time 
interaction effect: † p<0.05 
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Figure 1 Flow of participants through the study 
 
  
Excluded:
• Did not meet in/exclusion criteria: N=18
• Declined to participate: N=2
Started 1st intervention 
REHIT: N=10
Started 1st intervention 
Walking: N=11
Volunteered to 
participate:
N=21
Assessed for 
eligibility:
N=41
Dropped out:
• Unrelated medical 
issues: N=2
Dropped out:
• Lack of time: N=1
Started 2nd intervention 
Walking: N=9
Started 1st intervention 
REHIT: N=9
Dropped out:
• Unrelated medical 
issues: N=1
Dropped out:
• Personal reasons: 
N=1
Completed study: 
N=16
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Figure 2 Study diagram. ActiHeart devices were worn for 7 days prior to testing. Food 
diaries were kept for 3 days prior to testing. Abbreviations: BP: blood pressure, DEXA: dual-
energy X-ray absorptiometry, FAM: familiarisation V̇O2max test, MAX: V̇O2max test, OGTT: 
oral glucose tolerance test, REHIT: reduced-exertion high-intensity interval training, WALK: 
walking intervention. 
 
 
REHIT
WALK REHIT
WALKTE
S
T
T
E
S
T
T
E
S
T
T
E
S
T
Wash-out 
8 weeks 8 weeks 8 weeks
F
A
M
ActiHeart / food diary ActiHeart / food diary ActiHeart / food diary ActiHeart / food diary
24-hr continuous glucose monitoring
Time: 8:00               12:00                            18:00                           24:00                              9:00
OGTT
M
A
X
Snack Meal Snack Meal Snack Meal
D
E
X
A
BP
1 week
